Digital health to end tuberculosis in the Sustainable Development Goals era: achievements, evidence and future perspectives

Dennis Falzon, Giovanni Battista Migliori, Ernesto Jaramillo, Karin Weyer, Guy Joos, Mario Raviglione

Source: Eur Respir J, 50 (5) 1701632; 10.1183/13993003.01632-2017
Journal Issue: November
Disease area: Respiratory infections

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Dennis Falzon, Giovanni Battista Migliori, Ernesto Jaramillo, Karin Weyer, Guy Joos, Mario Raviglione. Digital health to end tuberculosis in the Sustainable Development Goals era: achievements, evidence and future perspectives. Eur Respir J, 50 (5) 1701632; 10.1183/13993003.01632-2017

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Digital health technology for the end TB strategy: Developing priority products and making them work
Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics
Year: 2016


Ensuring that the diagnosis of tuberculosis accelerates progress towards the Millennium Development Goals
Source: Eur Respir J 2014; 44: 1-4
Year: 2014


Digital health for the End TB Strategy: developing priority products and making them work
Source: Eur Respir J 2016; 48: 29-45
Year: 2016



The European union standards for tuberculosis care: Do they need an update?
Source: International Congress 2014 – Tuberculosis: public health and primary prevention
Year: 2014


Tuberculosis prevention must integrate technological and basic care innovation
Source: Eur Respir J 2016; 48: 1531-1532
Year: 2016


Asthma research in Europe: a transformative agenda for innovation and competitiveness
Source: Eur Respir J, 49 (5) 1602294; 10.1183/13993003.02294-2016
Year: 2017



Introduction: Pulmonary rehabilitation – strong foundations, new science and opportunities for innovation
Source: Eur Respir Monogr 2021; 93: ix-xiii
Year: 2021


Challenges, impact and the future
Source: Eur Respir Monogr 2019; 83: 240-244
Year: 2019


Information and education provision in bronchiectasis: co-development and evaluation of a novel patient-driven resource in a digital era
Source: Eur Respir J, 51 (4) 1702402; 10.1183/13993003.02402-2017
Year: 2018



Presenting the European Forum for TB Innovation: innovative thinking in progressing towards TB elimination in Europe},
Source: Eur Respir J 2012; 40: 806-808
Year: 2012


Translating scientific discoveries during pandemics: ensuring equity for people affected by COVID-19 and tuberculosis
Source: ERJ Open Res, 6 (4) 00562-2020; 10.1183/23120541.00562-2020
Year: 2020



Health outcomes assessment and economic evaluation in COPD: challenges and opportunities
Source: Eur Respir J 2003; 21: 1S-3S
Year: 2003


eTRIKS IT platfroms for large-scale biomedical research
Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Year: 2015

The ERS European Forum for TB Innovation in Europe: a new way to raise innovation
Source: Annual Congress 2013 –PG7 Tuberculosis: innovations in clinical and public health management
Year: 2013



Towards the elimination of tuberculosis: challenges ahead from a European perspective
Source: Annual Congress 2012 - Joint session with WHO and ECDC "Towards elimination of tuberculosis"
Year: 2012

Facts and perspectives in the development of new diagnostics
Source: Annual Congress 2008 - New insights into tuberculosis control
Year: 2008